Currently the Vice President of Quality Assurance and Compliance for Aurobindo Pharma USA Inc. with responsibility for Quality Assurance, Narcotic Compliance (DEA), Pharmacovigilance, and Compliance for the firm. Jeffrey (Jeff) has over 32 years of direct hands-on experience in solid dosage and injectable generic/brand product manufacturing. Previously maintained management rolls with Sun Pharma, Wyeth, Aventis and Baxter. Instrumental in remediating consent decree issues at both Wyeth and Aventis. Jeff began his career with Glaxo as a bench chemist at their first US manufacturing facility. He has a BS degree in Chemistry.